We found a higher rate of EGFR mutation in adenocarcinomas than over all (29.8% vs 20%) and among women than men (32% vs 23%), similar to Korean, Chinese and Japanese data as reported earlier [1], [13]–[15] (Table 1). This evidence concerns the gene EGFR and adenocarcinoma.